Article
Statistical power in COVID-19 case-control host genomic study design.
Genome medicine - 28 Dec 2020
Lin Yu-Chung, Brooks Jennifer D, Bull Shelley B, Gagnon France, Greenwood Celia M T, Hung Rayjean J, Lawless Jerald, Paterson Andrew D, Sun Lei, Strug Lisa J
Abstract excerpt
The identification of genetic variation that directly impacts infection susceptibility to SARS-CoV-2 and disease severity of COVID-19 is an important step towards risk stratification, personalized treatment plans, therapeutic, and vaccine development and deployment. Given the importance of study design in infectious disease genetic epidemiology, we use simulation and draw on current estimates of exposure,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
